[Contribution on the mode of action of oral ovulation inhibitors in humans. Report 2].
Mall-haefeli
M
M
Ludwig
K S
KS
Keller
M
M
Weber
W
W
D001695:Biology; D003267:Contraception; D003276:Contraceptives, Oral; D003338:Corpus Luteum; D003710:Demography; D004194:Disease; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006653:Histology; D008599:Menstruation Disturbances; D010053:Ovary; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D012106:Research; D013995:Time; D013997:Time Factors; D014566:Urogenital System
D003276:Contraceptives, Oral
Biology; Clinical Research; Contraception; Contraceptive Methods--pharmacodynamics; Contraceptive Methods--side effects; Corpus Luteum; Demographic Factors; Diseases; Family Planning; Genitalia; Genitalia, Female; Histology; Longterm Effects; Menstruation Disorders; Oral Contraceptives--pharmacodynamics; Oral Contraceptives--side effects; Ovarian Effects; Ovary; Physiology; Population; Population Dynamics; Research Methodology; Reversibility; Time Factors; Urogenital System